Home
Search Tab Our search works best when asked a question.

Today's Headlines

Health Alerts

Health News Feature

Future of Medicine

Health Observances

Product Recalls


Archives

Health News Feature Archive

Future of Medicine Archive

Please review the policies that apply to all areas of this site. Your continued use of the site means that you accept these policies.
Learn More:
Our Policies
About Us

TrustE Seal

Health on the Net Seal

We subscribe to the HONcode principles.

Verify here.

Home Email This Page
Printer Friendly Page

Blocking Drug-Related Memories May Prevent Relapses


Animal brain receptor study suggests new treatments for addiction in humans

WEDNESDAY, Aug. 13 (HealthDay News) -- It may be possible to prevent a drug addiction relapse by disrupting the brain's attempts to retrieve drug-associated memories, according to new research.

U.K. researchers reduced drug-seeking behaviors in rats by blocking their brain's NMDA-type glutamate receptor, which is vital for learning and memory, during the recall of drug-associated memories. Researchers have known that recalling memories linked to previous drug use, such as environmental cues, can cause recovering drug addicts to relapse.

The findings are published in the Aug. 13 issue of The Journal of Neuroscience.

In the study, researchers at the University of Cambridge trained rats to associate a light going on with receiving a dose of cocaine. They "reactivated" the memory by exposing the rats to the light without the cocaine infusion. Later, the rats continued to perform behaviors that turned on the light or learned to perform new behaviors to try to get more cocaine.

The rats' cocaine-seeking behaviors were reduced after the researchers gave the animals a chemical that interfered with the NMDA-type glutamate receptor. When the single treatment was given just prior to the reactivation session, it reduced or even stopped drug-seeking behavior for up to a month; however, when given after or without the reactivation session, it had no effect on subsequent drug-seeking behaviors.

The findings suggest combining existing therapy with properly timed use of NMDA receptor inhibitors may help addicts kick their habits. The U.S. Food and Drug Administration already has approved several NMDA receptor inhibitors, including the cough suppressant dextramethorphan and the Alzheimer's disease drug memantine.

More information

The Center for Substance Abuse Treatment has more about dealing with addiction.

SOURCE: Society for Neuroscience, news release, Aug. 12, 2008
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Health News Provided By:
HealthDay
© 2008 Healthvision. All Rights Reserved. .

Healthvision Logo